UBS ASSET MANAGEMENT AMERICAS LLC - BRIDGEBIO PHARMA INC ownership

BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 184 filers reported holding BRIDGEBIO PHARMA INC in Q3 2022. The put-call ratio across all filers is 0.89 and the average weighting 0.3%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS LLC ownership history of BRIDGEBIO PHARMA INC
ValueSharesWeighting
Q3 2023$18,343,842
+57.0%
695,633
-1.3%
0.01%
+33.3%
Q2 2023$11,680,3760.0%704,4860.0%0.01%0.0%
Q1 2023$11,680,376
+1374.4%
704,486
+577.6%
0.01%
Q4 2022$792,214
-99.9%
103,965
-3.6%
0.00%
-100.0%
Q3 2022$1,071,910,000
+39.4%
107,838
+27.3%
0.00%
Q2 2022$768,967,000
+15.7%
84,688
+29.4%
0.00%
Q1 2022$664,410,000
-38.7%
65,459
+0.8%
0.00%
Q4 2021$1,083,550,000
-67.3%
64,961
-8.1%
0.00%
-100.0%
Q3 2021$3,313,521,000
-21.4%
70,696
+2.2%
0.00%
-50.0%
Q2 2021$4,217,397,000
+73.6%
69,183
+75.4%
0.00%
+100.0%
Q1 2021$2,429,566,000
-79.3%
39,441
-76.2%
0.00%
-83.3%
Q4 2020$11,761,737,000
+79.8%
165,402
-5.2%
0.01%
+50.0%
Q3 2020$6,543,300,000
+13.4%
174,395
-1.4%
0.00%0.0%
Q2 2020$5,770,371,000
+17.8%
176,951
+4.7%
0.00%0.0%
Q1 2020$4,899,434,000
+82.2%
168,946
+120.2%
0.00%
+100.0%
Q4 2019$2,689,526,000
+62.8%
76,734
-0.3%
0.00%
+100.0%
Q3 2019$1,652,138,000
-18.3%
76,951
+2.6%
0.00%0.0%
Q2 2019$2,022,750,00075,0000.00%
Other shareholders
BRIDGEBIO PHARMA INC shareholders Q3 2022
NameSharesValueWeighting ↓
Aisling Capital Management LP 6,068,125$160,016,45665.94%
Kohlberg Kravis Roberts & Co. L.P. 31,060,971$819,077,80528.79%
Cormorant Asset Management, LP 4,662,530$122,950,9167.17%
Frazier Life Sciences Management, L.P. 2,725,949$71,883,2754.77%
Octagon Capital Advisors LP 971,639$25,622,1203.94%
M28 Capital Management LP 121,200$3,196,0443.66%
VIKING GLOBAL INVESTORS LP 25,120,991$662,440,5332.69%
BOONE CAPITAL MANAGEMENT LLC 313,381$8,263,8572.61%
Fernwood Investment Management, LLC 235,620$6,213,2992.23%
SOUTHPORT MANAGEMENT, L.L.C. 15,000$395,5502.15%
View complete list of BRIDGEBIO PHARMA INC shareholders